Bausch & Lomb Corp (BLCO.TO)
20.44
+0.68
(+3.44%)
CAD |
TSX |
May 07, 16:00
Bausch & Lomb Shareholders Equity (Quarterly): 9.016B for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 9.016B |
| December 31, 2023 | 9.084B |
| September 30, 2023 | 9.263B |
| June 30, 2023 | 9.219B |
| March 31, 2023 | 9.442B |
| December 31, 2022 | 9.541B |
| Date | Value |
|---|---|
| September 30, 2022 | 9.202B |
| June 30, 2022 | 8.884B |
| March 31, 2022 | 8.912B |
| December 31, 2021 | 11.89B |
| September 30, 2021 | 11.89B |
| December 31, 2020 | 12.65B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
8.884B
Minimum
Jun 2022
12.65B
Maximum
Dec 2020
9.916B
Average
9.241B
Median
Shareholders Equity (Quarterly) Benchmarks
| Bausch Health Companies Inc | -1.510B |
| Biocure Technology Inc | 2.586M |
| Core One Labs Inc | 5.641M |
| Nova Mentis Life Science Corp | -0.601M |
| Nanosphere Health Sciences Inc | -2.014M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 18.00B |
| Total Liabilities (Quarterly) | 8.887B |
| Debt to Equity Ratio | 0.6884 |
| Current Ratio | 1.696 |
| Net Debt Paydown Yield | -7.05% |